Lexicon Pharmaceuticals Company Profile (NASDAQ:LXRX)

About Lexicon Pharmaceuticals

Lexicon Pharmaceuticals logoLexicon Pharmaceuticals, Inc. (Lexicon) is a biopharmaceutical company. The Company focuses on the development of treatments for human disease. The Company is engaged in the development of two drug candidates: telotristat etiprate (LX1032) and sotagliflozin (LX4211). The Company's telotristat etiprate, is an orally delivered small molecule drug candidate, as a treatment for carcinoid syndrome. LX1032 inhibits tryptophan hydroxylase (TPH), which is an orally-delivered small molecule compound that the Company is developing for the treatment of carcinoid syndrome. Sotagliflozin, or LX4211, which is an orally-delivered small molecule compound that the Company is developing for the treatment of type 1 and type 2 diabetes mellitus. LX2761 is an orally-delivered small molecule compound for the treatment of diabetes. LX9211 is an orally-delivered small molecule compound for the treatment of neuropathic pain. The Company's other programs include LX1033, LX2931 and LX7101.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: LXRX
  • CUSIP: 52887210
Key Metrics:
  • Previous Close: $14.50
  • 50 Day Moving Average: $15.57
  • 200 Day Moving Average: $13.26
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.95
  • P/E Growth: -0.18
  • Market Cap: $1.51B
  • Outstanding Shares: 103,865,000
  • Beta: 1.42
Additional Links:
Companies Related to Lexicon Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Lexicon Pharmaceuticals (NASDAQ:LXRX) (?)
Ratings Breakdown: 3 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $21.42 (47.70% upside)

Analysts' Ratings History for Lexicon Pharmaceuticals (NASDAQ:LXRX)
Show:
DateFirmActionRatingPrice TargetDetails
8/11/2016Needham & Company LLCReiterated RatingBuyView Rating Details
8/5/2016Stifel NicolausBoost Price TargetBuy$25.00 -> $26.00View Rating Details
8/5/2016WedbushBoost Price TargetOutperform$30.00 -> $31.00View Rating Details
8/2/2016Citigroup Inc.Initiated CoverageBuy$21.00View Rating Details
5/5/2016JPMorgan Chase & Co.Reiterated RatingHold$16.00View Rating Details
5/3/2016Cowen and CompanyReiterated RatingMarket PerformView Rating Details
9/28/2015GabelliUpgradeSell -> Hold$13.50View Rating Details
(Data available from 8/26/2014 forward)

Earnings

Earnings History for Lexicon Pharmaceuticals (NASDAQ:LXRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/4/2016        
8/4/2016Q216($0.41)($0.37)$12.36 million$20.10 millionViewN/AView Earnings Details
5/3/2016Q1($0.30)($0.34)$11.11 million$12.50 millionViewN/AView Earnings Details
3/1/2016Q415($0.38)$0.76$21.50 million$127.30 millionViewN/AView Earnings Details
11/6/2015Q3($0.36)($0.34)$0.45 millionViewN/AView Earnings Details
8/7/2015Q215($0.32)($0.27)$0.45 million$376.00 millionViewN/AView Earnings Details
4/29/2015Q115($0.04)($0.04)$1.10 million$1.78 millionViewN/AView Earnings Details
11/4/2014Q3($0.05)($0.08)$0.16 million$0.40 millionViewN/AView Earnings Details
8/7/2014Q214($0.05)($0.05)$0.13 million$0.68 millionViewN/AView Earnings Details
5/8/2014Q114($0.05)($0.06)$0.12 million$277.00 millionViewN/AView Earnings Details
2/28/2014Q413($0.06)($0.03)$1.66 million$1.40 millionViewN/AView Earnings Details
11/12/2013Q3($0.01)($0.06)$1.59 million$0.24 millionViewListenView Earnings Details
2/21/2013Q4 2012($0.05)($0.05)$0.37 million$0.22 millionViewN/AView Earnings Details
11/6/2012Q312($0.06)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Lexicon Pharmaceuticals (NASDAQ:LXRX)
Current Year EPS Consensus Estimate: $-1.54 EPS
Next Year EPS Consensus Estimate: $-1.62 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.37)($0.37)($0.37)
Q2 20161($0.35)($0.35)($0.35)
Q3 20161($0.46)($0.46)($0.46)
Q4 20161($0.18)($0.18)($0.18)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Lexicon Pharmaceuticals (NASDAQ:LXRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Lexicon Pharmaceuticals (NASDAQ:LXRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/6/2016James F TessmerVPSell1,500$15.00$22,500.00View SEC Filing  
5/23/2016James F TessmerVPSell6,000$13.00$78,000.00View SEC Filing  
12/12/2014C.V. InvusDirectorBuy150,000$0.88$132,000.00View SEC Filing  
12/10/2014C.V. InvusDirectorBuy315,896$0.90$284,306.40View SEC Filing  
11/26/2014International S.C.A. ArtalDirectorBuy149,253,731$1.01$150,746,268.31View SEC Filing  
10/23/2012International S.C.A. ArtalDirectorBuy3,000,000$2.25$6,750,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Lexicon Pharmaceuticals (NASDAQ:LXRX)
DateHeadline
capitalcube.com logoLexicon Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : LXRX-US : August 25, 2016 (NASDAQ:LXRX)
www.capitalcube.com - August 25 at 11:05 AM
finance.yahoo.com logoLEXICON PHARMACEUTICALS, INC. Financials (NASDAQ:LXRX)
finance.yahoo.com - August 12 at 6:07 PM
mysmartrend.com logoLexicon Pharmaceuticals Up 40.8% Since SmarTrend Uptrend Call (LXRX) (NASDAQ:LXRX)
www.mysmartrend.com - August 11 at 6:24 PM
streetupdates.com logoAnalysts Suggestion Alert: XOMA Corporation (NASDAQ:XOMA ... - Street Updates (NASDAQ:LXRX)
www.streetupdates.com - August 6 at 8:53 AM
finance.yahoo.com logoEdited Transcript of LXRX earnings conference call or presentation 4-Aug-16 2:00pm GMT (NASDAQ:LXRX)
finance.yahoo.com - August 5 at 6:13 PM
biz.yahoo.com logoLEXICON PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements (NASDAQ:LXRX)
biz.yahoo.com - August 4 at 6:22 PM
twst.com logoLexicon Pharmaceuticals Inc.: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2016 Second Quarter Financial Results (NASDAQ:LXRX)
www.twst.com - August 4 at 9:07 AM
finance.yahoo.com logoLexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Second Quarter Financial Results (NASDAQ:LXRX)
finance.yahoo.com - August 4 at 9:07 AM
sg.finance.yahoo.com logoLexicon reports 2Q loss (NASDAQ:LXRX)
sg.finance.yahoo.com - August 4 at 9:07 AM
finance.yahoo.com logoCoverage initiated on Lexicon Pharma by Citigroup (NASDAQ:LXRX)
finance.yahoo.com - August 2 at 6:22 PM
finance.yahoo.com logoLexicon To Report Second Quarter 2016 Financial Results On August 4, 2016 (NASDAQ:LXRX)
finance.yahoo.com - August 1 at 5:53 PM
News IconFBR Analyst Weighs In on Anavex Life Sciences Corp (NASDAQ:LXRX)
poderygloria.net - July 29 at 6:14 PM
equities.com logoLexicon Pharmaceuticals Inc. (LXRX) Hits New 52-week High During July 26 Session - Equities.com (NASDAQ:LXRX)
www.equities.com - July 29 at 6:13 PM
equities.com logoLexicon Pharmaceuticals Inc. (LXRX) Hits New 52-week High During July 26 Session (NASDAQ:LXRX)
www.equities.com - July 28 at 9:13 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - TGP (NASDAQ:LXRX)
telanaganapress.com - July 23 at 10:00 AM
finance.yahoo.com logoLexicon Announces The Validation By The European Medicine Agency Of The Marketing Authorization Application … (NASDAQ:LXRX)
finance.yahoo.com - July 18 at 6:11 PM
finance.yahoo.com logoLexicon Announces The Validation By The European Medicine Agency Of The Marketing Authorization Application For Telotristat Etiprate For The Treatment Of Carcinoid Syndrome (NASDAQ:LXRX)
finance.yahoo.com - July 18 at 4:01 PM
News IconShares Moving Down on the Week: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Engelwood Daily (NASDAQ:LXRX)
www.engelwooddaily.com - July 18 at 11:21 AM
News IconStock in Positive Territory for the Quarter: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Engelwood Daily (NASDAQ:LXRX)
www.engelwooddaily.com - July 18 at 11:21 AM
News IconTrading Performance and Target Watch for Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Press Telegraph (NASDAQ:LXRX)
presstelegraph.com - July 18 at 11:21 AM
News IconShare Performance Summary for: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Press Telegraph (NASDAQ:LXRX)
presstelegraph.com - July 18 at 11:21 AM
News IconCrowd Rating and Earnings Recap for Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Telanagana Press (NASDAQ:LXRX)
telanaganapress.com - July 15 at 10:23 AM
News IconAnalyst Target and Average Rating Watch: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Press Telegraph (NASDAQ:LXRX)
presstelegraph.com - July 14 at 9:38 AM
News IconCould Lexicon Pharmaceuticals, Inc. Change Direction After Today's Huge Decline? - Consumer Eagle (NASDAQ:LXRX)
www.consumereagle.com - July 14 at 9:38 AM
News IconIntraday Active Biotech Stocks News: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Sage Therapeutics, Inc ... - The Voice Registrar (NASDAQ:LXRX)
voiceregistrar.com - July 14 at 9:38 AM
News IconShares Moving Up Over the Past Quarter: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Engelwood Daily (NASDAQ:LXRX)
www.engelwooddaily.com - July 12 at 6:17 PM
fiscalstandard.com logoBroker Outlook For The Week Ahead Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Fiscal Standard (NASDAQ:LXRX)
www.fiscalstandard.com - July 10 at 5:33 PM
News IconLexicon Pharmaceuticals Incorporated (NASDAQ:LXRX) Sellers Increased By 1.53% Their Shorts - Engelwood Daily (NASDAQ:LXRX)
www.engelwooddaily.com - July 9 at 9:25 AM
News IconFast Growth for Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Telanagana Press (NASDAQ:LXRX)
telanaganapress.com - July 8 at 8:56 AM
publicnow.com logoLexicon to Present at the Cantor Fitzgerald Healthcare Conference (NASDAQ:LXRX)
www.publicnow.com - July 7 at 4:31 PM
fiscalstandard.com logoLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Current Analyst Ratings - Fiscal Standard (NASDAQ:LXRX)
www.fiscalstandard.com - July 7 at 8:57 AM
News IconStock Tracking Down This Month; Investor Alert on Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Engelwood Daily (NASDAQ:LXRX)
www.engelwooddaily.com - July 6 at 10:42 AM
fiscalstandard.com logoLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:LXRX)
www.fiscalstandard.com - July 6 at 10:42 AM
News IconFast Growing Stock: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Telanagana Press (NASDAQ:LXRX)
telanaganapress.com - July 6 at 10:42 AM
News IconShare Performance Recap for: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Press Telegraph (NASDAQ:LXRX)
presstelegraph.com - July 3 at 5:34 PM
news.cmlviz.com logoLexicon Pharmaceuticals, Inc. Stock Momentum Hits Strength - CML News (NASDAQ:LXRX)
news.cmlviz.com - June 29 at 5:57 PM
News IconWhat's Ahead for Lexicon Pharmaceuticals, Inc. After Today's Huge Increase? - Engelwood Daily (NASDAQ:LXRX)
www.engelwooddaily.com - June 29 at 5:57 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Fiscal Standard (NASDAQ:LXRX)
www.fiscalstandard.com - June 27 at 10:23 AM
News IconEquity Research and Technical Review on Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Press Telegraph (NASDAQ:LXRX)
presstelegraph.com - June 27 at 10:23 AM
News IconStock Performance Focus on: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Press Telegraph (NASDAQ:LXRX)
presstelegraph.com - June 27 at 10:23 AM
finance.yahoo.com logoFrank Palantoni joins Laboratoire M2 as CEO (NASDAQ:LXRX)
finance.yahoo.com - June 22 at 10:00 AM
fiscalstandard.com logoRecently Issued Stock Ratings For Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Fiscal Standard (NASDAQ:LXRX)
www.fiscalstandard.com - June 21 at 5:43 PM
capitalcube.com logoETF’s with exposure to Lexicon Pharmaceuticals, Inc. : June 21, 2016 (NASDAQ:LXRX)
www.capitalcube.com - June 21 at 1:08 PM
capitalcube.com logoLexicon Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : LXRX-US : June 20, 2016 (NASDAQ:LXRX)
www.capitalcube.com - June 20 at 8:29 AM
fiscalstandard.com logoLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Analyst Price Targets For The Coming Week - Fiscal Standard (NASDAQ:LXRX)
www.fiscalstandard.com - June 20 at 7:28 AM
News IconTrending Analyst Recommended Stock: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - News Oracle (NASDAQ:LXRX)
www.newsoracle.com - June 17 at 8:49 AM
streetupdates.com logoStock's Price Moves: Cerus Corporation (NASDAQ:CERS) , Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Street Updates (NASDAQ:LXRX)
www.streetupdates.com - June 13 at 8:55 AM
investornewswire.com logoWill Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Surprise Analysts? - Investor Newswire (NASDAQ:LXRX)
www.investornewswire.com - June 12 at 8:47 AM
news.cmlviz.com logoLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Fundamental Star Rating Report - CML News (NASDAQ:LXRX)
news.cmlviz.com - June 9 at 6:18 PM
capitalcube.com logoETF’s with exposure to Lexicon Pharmaceuticals, Inc. : June 9, 2016 (NASDAQ:LXRX)
www.capitalcube.com - June 9 at 1:27 PM

Social

Lexicon Pharmaceuticals (NASDAQ:LXRX) Chart for Friday, August, 26, 2016


Last Updated on 8/26/2016 by MarketBeat.com Staff